Contact this trialFirst, we need to learn more about you.
Phosphate Binder
Oxylanthanum Carbonate for Chronic Kidney Disease
Recruiting1 awardPhase 2
Fort Myers, Florida
This trial aims to test if patients with chronic kidney disease on hemodialysis and high levels of phosphorus can tolerate a new drug called oxylanthanum carbonate (OLC). Participants will replace
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.